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INTRODUCTION 
The functional maturation of bone marrow (BM)-derived dendritic cells (DC) is 
now thought to reflect the upregulated expression of a variety of cell surface molecules 
that are important in antigen presentation, intercellular adhesion and T cell stimulation. 
These comprise major histocompatibility complex (MHC) antigens, and both intercellular 
adhesion (e.g. CD54 and CD58) and T cell stimulatory molecules, especially the CD28 
ligands B7-1 (CD80) and B7-2 (CD86) (1,2). Although mature DC are the most potent 
antigen-presenting cells (APC) and inducers of naive T cell activation (3,4), there is also 
evidence that they playa role in central tolerance induction (5-7) within the thymus. 
More recently, it has been suggested that DC progenitors or functionally immature DC, 
that are deficient as inducers of allogeneic T cell responses, may playa role in 
peripheral tolerance (8-10). Moreover, the CD28 structural homologue CTLA4-Ig, a 
fusion protein that blocks CD28-mediated T cell stimulation inhibits T cell proliferation 
in allogeneic mixed leukocyte reactions (MLR) (11, 12). In addition, it induces 
hyporesponsiveness to alloantigen in vitro (11) and donor-specific tolerance in 
cardiac-allografted mice (13). 
Recently, we have shown that small numbers of donor-derived DC progenitors 
(14) can be propagated in response to G M-CSF from the BM of unmodified murine liver 
allograft recipients that accept their grafts spontaneously (15,16). This finding has 
provoked questions about the function of donor-derived, GM-CSF stimulated BM DC 
progenitors in relation to tolerance induction. In this study, we have investigated the 
Immature Dendritic Cells luduce T cell ... 
R.G. Landes Co. 
function of BM-derived DC progenitors in allogeneic systems in vitro and tested their 
influence on cardiac allograft rejection. 
MATERIALS AND METHODS 
Animals. Ten to twelve-week old C57BL/lOJ (BlO; H-2b, I-Ab, I-E') and 
C3H/HeJ (C3H; H-2\ I-A\ I-Ek) mice were obtained from The Jackson Laboratory, Bar 
Harbor, ME. 
Propagation of hone mwTOW (BM)-derived DC. Bone marrow (BM) cell 
suspensions were prepared in RPMI-1640 (Gibco, Grand Island, NY) using conventional 
procedures. Two x 106 cells were cultured in 24-well plates in RPMI-1640 supplemented 
with 10% v/v fetal bovine serum (Gibco) and 500 U(2ng)/ml recombinant(r) mouse 
GM-CSF (Schering-Plough, Kenilworth, NJ). In some experiments, the culture medium 
was supplemented with r mouse IL-4 (Schering-Plough; 1000 Vlml) in addition to GM-
CSF. The procedure used was modified (17) after that described by Inaba et al (18) for 
the propagation of large numbers of DC progenitors from normal mouse BM. The 
medium containing GM-CSF ± IL-4 was refreshed every two days. 
Staining of cell surlace antigens. Cell surface staining was analyzed by 
cytofluorography using a FACScan· flow cytometer (Becton Dickinson & Co., Mountain 
View, CA) as previously described (17). Staining with primary hamster or rat 
monoclonal antibodies (mAbs), including rat anti-B7-I and B7-2 (PharMingen, San 
Diego, CA) was followed by FITC-conjugated goat anti-hamster or mouse anti-rat Igs, as 
described (17,19). MHC class I and class II positive cells were identified using biotin-
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conjugated mouse anti-mouse mAbs (PharMingen, San Diego, CA) with FITC 
streptavidin (Jackson Immunoresearch Labs Inc., West Grove, PA) as the secondary 
reagent. 
Mixed leukocyte reactions (MLR) and testing for T cell hyporesponsiveness. 
Splenocytes for use as responder cells, were depleted of red blood cells by lysis in Tris-
buffered NH4CI then T-cell enriched (> 95%) by sequential removal of plastic-adherent 
cells (1 hr at 37°C) and high affinity negative selection by passage (10 min at room 
temperature) through a Mouse T Cell Enrichment Column (R & D Systems, Inc., 
Minneapolis, MN). For MLR 2 x 105 T cells were cultured with graded concentrations 
of 'Y-irradiated (20 Gy) allogeneic stimulator cells in 0.2 ml of medium for 3 days in 96-
well, round-bottom tissue culture plates in 5% CO2 in air. Alternatively, for primary 
MLR, 2 x 106 T cells were incubated with 1 x 106 stimulators in 24-well plates in 2 ml of 
medium. In some experiments, hamster anti-CD28 mAb (Pharmingen; 25JLg/ml) or 
control hamster IgG was added to the primary MLR. After 2 days, the cells were 
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harvested, washed in medium and depleted of la + cells with anti-I-Ail mAb (Pharmingen) 
plus low toxicity rabbit complement (Accurate Chemical & Scientific Corp., Westbury, 
NY) (17). Viable cells were isolated by centrifugation over Ficoll-Isopaque for 15 min at 
350,g and rested in medium for 2 days in the absence of stimulators. The pretreated T 
cells were then restimulated with freshly-isolated, ,-irradiated spleen cells in the absence 
or presence of r human IL-2 (Gibco; SOU Iml) in a secondary, 3-day MLR in lJ6-well 
round-bottom plates. For the final 18 he lOJLl [.lH] TdR (lJLCi) was added to each well. 
Cells were harvested onto glass fiber disks using a multiple cell harvester and the degree 
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of thymidine incorporation was determined in a liquid scintillation counter. Results were 
expressed as mean counts per minute (cpm) ± ISO. 
IL-2 assay. IL-2 levels in MLR culture supernatants were determined by the 
CTLL cell assay (20). 
Heterotopic heart transplantation. The method for heterotopic heart 
transplantation was adapted from the rat procedure of Ono and Lindsey (21). The heart 
was transplanted into the abdomen with end to side anastomosis of aorta to aorta and 
pulmonary artery to vena cava. Rejection was defined by the cessation of cardiac 
contraction after daily palpation through the abdominal wall, and confirmed by 
histological examination. No immunosuppressive therapy was used. To test the 
influence of cultured cells on heart allograft survival, 2 x 106 cells were injected i.v. in 0.2 
ml medium via the lateral tail vein, 7 days hefore organ transplantation. 
RESULTS 
Immunopilellotypic wlr~vsis of GM-CSF stimulated cells. The surface 
immunophenotype of cells released after H-lO days from proliferating aggregates in GM-
CSF stimulated cultures was characterized hy flow cytometric analysis. Staining for cells 
of lymphoid lineage, including NK cells, was ahsent. The floating cells did however, 
stain for surface antigens that are known to he associated with mouse DC. These 
included CD45 (leukocyte common antigen), MHC class I, heat stahle antigen (J 11 D), 
CD54 (intercellular adhesion molecule-I; ICAM-I), CDllb (MAC-I) and CD44 
(nonpolymeric determinant of Pgp.I glycoprotein). In addition, staining of moderate 
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intensity was observed for the mouse DC-restricted cell surface markers NLDC-145 
(interdigitating cells), 3301 and COllc (N41S; ,B2-integrin), for the macrophage antigen 
F4/S0 and for Fc-yRII (C032), as described previously (IS) for mouse BM-derived DC 
(data not shown). The GM-CSF stimulated BM-derived cells expressed moderate levels 
of cell surface MHC class II (I-Ab). 
Upregulation of MHC class II, B7-1 and 87-2 expression on GM-CSF + IL-4 
stimulated BM-derived DC. Cells stimulated with GM-CSF either alone or in 
combination with IL-4 were harvested after H - 10 days and compared for the expression 
of surface markers linked with T cell stimulatory function. A marked difference was 
consistently observed between the two cell populations with respect to the intensity of 
expression of MHC class II and the C02H ligands, B7-1 (COSO) and B7-2 (COS6). On 
cells stimulated with GM-CSF (500 U /ml) alone, MHC class II was positive, B7-1 
expression was low, whereas B7-2 was negligible/dim (Fig. 1). An increase in GM-CSF 
concentration from SOO-lOOO U /ml augmented the intensity of staining for each of these 
molecules (data not shown). However. expression of MHC class II, and especially B7-2, 
was markedly and consistently upregulated on cells treated with both cytokines (Fig. 1). 
The GM-CSF stimulated MHC class 11+ B7_1111w B7-2' and the GM-CSF plus IL-4 
induced MHC class 11+ B7-1 + B7-2+ populations are subsequently referred to herein as 
B7-2' and B7-2+ DC, respectively. 
MLR stimu{atOl)' activity of "ill1mallire" (87-2) and "mature" (87-2+) DC. The 
GM-CSF + IL-4 stimulated B 10 BM-derived DC that were MHC class II. + B7-1 + and 
B7-2+ were highly potent inducers of primary allogeneic (C3H) T cell responses in 3-day 
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primary mixed leukocyte cultures (data not shown). The possibility that this high MLR 
stimulatory activity was due to "carry over" of IL-4 was excluded, as GM-CSF + IL-4-
stimulated B7-2+ DC did not induce syngeneic T cell proliferation. On the basis both of 
immunophenotype and T-cell stimulatory activity, the B7-2+ cells were considered to be 
mature DC. In contrast, GM-CSF stimulated MHC class 11+ B7_1 1oW B7-2" BM-derived 
cells were much poorer inducers of allogeneic T cell activation and exhibited a 
comparatively low level of MLR-stimulatory activity. This was consistent with their low 
level of cell surface B7-2 and was similar to that of freshly-isolated, bulk B10 spleen 
cells. The B7-2" cells were therefore considered to be functionally immature DC. 
Induction of alloantigen-specific T celllzyporesponsiveness hy B7-2- BM-derived DC. 
Purified C3H splenic T cells were stimulated initially with either freshly isolated B 10 
bulk spleen cells or GM-CSF stimulated (B7-2-) or GM-CSF + IL-4 stimulated (B7-2+) 
B10 BM DC; after resting for 2 days, the primed C3H T cells were restimulated in a 
secondary MLR with fresh B1O, C3H (syngeneic) or BALB/c (third party) splenocytes. 
As shown in Fig. 2, the T cells stimulated with B7-2+ B10 DC in a primary MLR 
displayed strong proliferative responses when restimulated with B 10 spleen cells. In 
contrast, T cells exposed initially to B 10 B7-2- BM DC responded only weakly upon 
restimulation with B 10 splenocytes and at a lower level than C3H T cells primed with 
fresh B 10 splenocytes. The same T cells however, displayed proliferative responses to 
third party (BALB/c) spleen cells, indicating that the hyporesponsiveness was donor-
specific (data not shown). The addition of anti-CD28 mAb to primary MLR cultures 
significantly increased the allostimulatory function of immature BM DC. Furthermore, 
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priming of allogeneic T cells with B7-2- DC in the presence of anti-CD28 prevented 
hypo responsiveness in secondary MLR. 
T cell hyporesponsiveness induced hy 87-2- DC is associated with impaired IL-2 
production. To determine whether the induction of hyporesponsiveness in C3H T cells 
was linked to blockade of IL-2 production, levels of IL-2 were determined by bioassay in 
supernatants harvested from B 10 restimulated T cells primed initially with B 10 
splenocytes, B7-2- B 10 DC or B7-2- DC in the presence of anti-CD28. C3H T cells 
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primed with B7-2- DC failed to produce IL-2 in 2° MLR (data not shown). The presence 
of anti-CD28 in the 1 ° MLR however, prevented subsequent unresponsiveness. 
Hyporesponsive T cells primed by B7-2- BM-derived DC responded normally to 
alloantigen + exogenous IL-2 (50 U /ml) added at the outset of the secondary MLR 
(data not shown). Collectively, these findings strongly suggest the importance of an IL-2 
production defect in the induction of the hyporesponsive state. 
87-2- 8M-derived DC prolong cardiac allograft survival. B7-2- B 10 BM-derived DC 
(2 X 106 i.v.) given 7 days hefore organ transplant, prolonged the median survival time 
(MST) of B10 cardiac allografts in C3H mice (Tahle 1) from 9.5 to 22 days. Third party 
(BALB/c) B7-2- BM-derived DC however, also prolonged B 10 heart graft survival, 
although the MST was significantly less than that achieved with donor-specific B7-2- DC. 
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DISCUSSION 
In contrast to classical mature DC (3), functionally immature, MHC class IP, B7-
1 dim, B7-2' BM-derived DC, propagated in response to GM-CSF induced alloantigen-
specific hyporesponsiveness in T cells upon rechallenge in vitro. This hyporesponsive 
state was prevented by stimulation via the CD28 pathway and reversed by exogenous IL-
2. BM DC stimulated with GM-CSF + IL-4 exhibited an overall similar phenotype to 
the immature DC, but stained intensely for B7-2 in addition to enhanced B7-1 and high 
MHC class II antigen expression. In contrast to the B7-2' DC, these cells were very 
potent allostimulators. Our findings are consistent with those of Hathcock etal (22) who 
showed that quantitative differences in B7-1 and B7-2 expression on murine APC (B 
cells) could profoundly affect their contribution to costimulatory function. 
Immature MHC class IP DC that are B7-2' may (as is the case with inhibition of 
B7-2 [22]), allow TCR-mediated signalling events to occur but inhibit the distinct 
costimulatory signal(s) that are necessary for optimal cytokine production and cytokine-
dependent T cell proliferation. Thus, antigen presentation by APC that are unable to 
deliver adequate costimulatory signals induces neither of the gene transcription factors 
NF-AT or NF-kB (23). 
In principle, the induction of irreversible T cell anergy to donor-specific 
alloantigens in vivo (tolerance) would eliminate the need for potentially toxic, non-
specific immunosuppressive agents which currently constitute first choice anti-rejection 
therapy. Thus, there has heen considerahle interest in evidence that blockade of the B7-
CD28 T-cell costimulatory pathway is both necessary and sufficient to induce antigen-
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specific T cell anergy (24). Although the co-stimulatory signals delivered to T cells by 
APCs are neither antigen-specific nor MHC-restricted, they determine the outcome of 
TCR signaling as they mediate cytokine secretion. Co-ligation of the T cell 
CD28/CTLA-4 receptors (an essential stimulus of T cell activation) (25) by the APC 
<) 
counter-receptors B7 /BB 1 (CD80) or the recently identified 870/B7-2 (CD86) (22,26,27) 
results in IL-2 production and T cell proliferation (25,26,27). It is thought that this is 
achieved either by increased IL-2 mRNA transcription (28,29) or mRNA stability (30). 
Elicitation of strong IL-2 production by T cells has long been recognized as a 
characteristic of antigen-presenting DC (31,32). 
Although DC express several adhesion and costimulatory molecules (CD lla, 
CD44, CD54, CD48/58, C080 and C086), B7-2 appears to be the major C028/CTLA-4 
ligand and accounts for the costimulation provided by this pathway during in vitro 
immune responses. Indeed, in a recent study, anti-C080 (B7-1) mAbs failed to inhibit 
human dendritic Langerhans cell-induced alloactivation of T cells (33). Early and 
sustained expression of B7-2 mRNA (within 8 hr) (before maximal B7-1 expression) in 
activated murine B cells (34), suggests that it may provide a critical signal involved in the 
decision hetween activation or inactivation of T cells within 24 hr of stimulation (35,36). 
Moreover, APCs from mice in which the B7-1 gene has been knocked out express B7-2 
and are competent APCs (34). 
T cell co-stimulation mediated by C028 is important in the mediation of 
transplant rejection and the development of new therapeutic immunosuppressive 
strategies. Thus the combination of anti-B7 mAb with cyclosporine A induces 
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alloantigen-specific anergy in vitro (37). CTLA4-Ig, a fusion protein that blocks the 
CD28-mediated costimulatory signal inhibits T cell proliferation in allogeneic MLR 
(22,39), and induces hyporesponsiveness to alloantigen in vitro (11). Moreover, it 
prolongs MHC-mismatched cardiac allograft survival in rats (38,39) and induces donor-
specific transplantation tolerance to skin grafts in cardiac-allografted mice (13). 
Propagation of B7-2- immature DC with the capacity to induce alloantigen-specific 
hyporesponsiveness has significant in vivo implications. We have shown that immature 
DC can be propagated from the liver in response to GM-CSF. Conceivably, the 
tolerogenicity of liver allografts may be linked, at least in part, to the release of 
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potentially T cell anergizing DC from the liver, a pseudo-haemopoietic organ (40). This 
is likely to occur under the intluence of locally-produced GM-CSF (41) and possibly 
other growth promoting cytokines. The failure of the B7-2- DC to induce complete 
unresponsiveness (anergy) in vitro or indefinite cardiac allograft survival however, 
suggests that considerations of the cellular therapy of allograft rejection using immature 
donor-derived DC should include the use of adjunctive immunosuppression, 
implementing drugs or molecular approaches geared to inhibit costimulatory molecule 
expression on APC. 
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FIGURE LEGENDS 
FIGURE 1. FACScan" analysis of MHC class II (I-Ab), B7-1 and B7-2 expression on 
(above) 8-day GM-CSF and (below) 8-day GM-CSF + IL-4 stimulated BlO BM-derived 
bone marrow DC. Further details are provided in the Methods or have been described 
(17). "Shaded" profiles denote appropriate Ig isotype subclass controls. The result is 
representative of 3 separate experiments. 
FIGURE 2. Stimulation with B7-2- BM-derived DC during a primary MLR induces 
hyporesponsiveness upon restimulation in secondary MLR. C3H splenic T cells (2 x 
17 
106/ml at 1:2 [S:R]) ratio were stimulated during a primary MLR with either ),-irradiated 
(0) GM-CSF stimulated B 108M-derived DC (87-2-), (.) GM-CSF + IL-4 stimulated 
B 10 BM-derived DC (B7-2 +) or (t.) fresh B 1 0 spleen cells. The T cells were rested for 
2 days then restimulated with graded concentrations of freshly-isolated B 10 spleen cells. 
The results are expressed as mean counts per minute (cpm) ± ISD and are 
representative of four separate experiments. 
~ture Dendritic Celb Induce T cell .•. 
it.;;;. /Andes Co. 
18 
Table 1 Influence of donor-specific GM-CSF stimulated bone-marrc.w.t (BM)-derived DC (B7-:::-) 
on cardiac allograft survi\-a1. 
~Klis injected (day-7) Graft 5lUTVival times (days) MST Eda!~;F 
None 8.::2,13,13,8,9,10,8 9.5 
BI0 B~[ 12,12,12,12 12 
BlO B~d-aC 19. :D~ . .19,22,22,23,27,35 22 I 
C3H Ehl-DC (syngeneic) 12,12,13,13 12.5 p<0.02 
BALE::: BM-DC (third party) : -. _17, 12, 16,20, 19 17 -.J 
BID ~!-en-aC EBT-O~F 8,8,9 8.5 
EXPRESSION OF MEC II (I-Ah) , B7-1 AND B7-2 ON GM-CSF AND GM-CSF + IL-4 
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